RT @smerv: #ASH13 89% ALL patients have CR w/ CAR-modified T cells. Median follow 3.5 mos., one 18 mo. 6 of 27 relapse. Dr Kalos @penn

10:43am December 7th 2013 via Hootsuite in reply to